Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

DUBLIN, Mar. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug

) has announced the addition of the

"Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)"

conference to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London



KEY TOPICS TO INCLUDE:


- Market trends


- Human factors and useability


- Fluid dynamics - modelling the realities of injection performance


- Delivery of high viscosity drugs


- Case study presentation on devices in development


- Latest self injection trends


- Development of a parenteral device


- Delivery of high volumes


- Compliance modelling and parenteral drug delivery


- The insulet drug delivery system



DATES:



26 & 27 March 2014



TIMES:



Day One: 26 March 2013


Start times: 9.30 Finish 17.45



Drinks Reception Followed by Dinner 19.30



Day Two: 27 March 2013


Start times: 9.00 Finish 16.15



VENUE FOR CONFERENCE AND DINNER:



Le Meridien Hotel, Piccadilly, London



NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.



Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged



Key Topics Covered:



INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013



09.30 - Chairman's Welcome and Introduction


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.40 - Key Note Address: Market Trends



- High concentration formulations



- Larger doses, less frequent injections


Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA



10.20 - Human Factors and Useability



- Ethonographic research on atuoinjector use for chronic conditions



- Relationship between a disease and its therapy - emotional and functional levels



- How this affects device selection


Mathew Young, CEO, Oval Medical Technologies Ltd, UK



11.00 - Discussion followed by Coffee



11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance



- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early



- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device



- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later



- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken



- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user



- Early understanding of device issues supports and enables robust designs and capable manufacture



- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible


Andy Fry, Founder, Team Consulting, UK



12.10 - Delivery of High Viscosity Drugs



- Device formats



- Overcoming the challenges


Speaker, (invited)



12.50 - Discussion followed by Lunch



14.10 - Mixing Technologies for Reconstitution Devices



- Market Needs - Industry drivers and demands for these types of devices



- Latest mixing technologies



- Comparison of Lyophilised and Spray drying technologies



- Technical challenges with these types of devices


Tom Bailey, Managing Director, 3PInnovation, UK



14.50 - Device Case Study


Ian Anderson, Innovation Director, Bespak UK (invited)



15.30 - Discussion followed by Tea



16.10 - Latest Self Injection Trends



- General market trends



- Trends for biologics



- Trends for generics



- Pre-configured devices



- Future outlook


Mats Persson, Managing Director, SHL Group, Sweden



16.50 - Innovation in Primary Container Materials



- Trends for user requirements intended for self injection



- Material technology options and selection criteria



- Integration of Quality by Design for components



- Platform approach for lifecycle management


Tibor Hlobik, West Pharmaceutical Services



17.30 - Discussion



17.45 - End of Day One



19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London



INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013



09.00 - Review of Day One


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.10 - What Does Pharma Want From its Drug Delivery Suppliers


Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK



09.50 - Pump Technology Case Study


Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)



10.30 - Discussion followed by Coffee



11.10 - Compliance Monitoring and Parenteral Drug Delivery



- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)



- Advances in wireless communications enabling intelligent compliance monitoring



- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education



- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient



- Regulatory issues associated with connected health systems and smartphone apps



- Using the cloud to store and disseminate data securely


Mark Tuckwell, Senior Consultant, Connected Health Systems,


Sagentia, UK



11.50 - Wireless Communication and Electronics for Compliance Monitoring



- Patient therapy compliance continues to be one of the biggest challenges in health systems



- 50% of all patients do not complete required treatment



- Reasons for the high rate of non-compliance



- Opportunities for medical manufacturers to offer innovative solutions



- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers



- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance


Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel



12.30 - Discussion followed by Lunch



14.00 - Update on Regulations and Standards


Lee Leichter, President P/L Medical, USA



14.40 - The Insulet Drug Delivery System



Consists of two components


- Drug Delivery Pod


- Drug Delivery Manager



A Programmable, body worn, disposable, subcutaneous infusion pump



- Delivers up to 2ml of drug product over a three day period


- Delivery rate from 0.5 to 300 µl/hr


- Automated catheter insertion


- Waterproof (IPX8 25 feet for up to 60 minutes)



Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems


Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA



15.20 - The Rise of the Bolus Injector



The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:



- The changing needs of patients and new drugs



- Could autoinjectors and infusion pumps meet the needs?



- Bolus injectors: a new class of injection device



- Example devices



- What to expect from the draft standard ISO 11608-6' on bolus injectors.


Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK



16.00 - Discussion and Chairman's Closing Remarks



16.15 - End of Conference and Tea




For more information visit

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact:

Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across supply chain networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost and time for product recall as well as advance trade. Are you curious about Blockchain and how it can provide you with new opportunities for innovation and growth? In her session at 20th Cloud Exp...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing be...
Back in February of 2017, Andrew Clay Schafer of Pivotal tweeted the following: “seriously tho, the whole software industry is stuck on deployment when we desperately need architecture and telemetry.” Intrigue in a 140 characters. For me, I hear Andrew saying, “we’re jumping to step 5 before we’ve successfully completed steps 1-4.”
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
NHK, Japan Broadcasting, will feature the upcoming @ThingsExpo Silicon Valley in a special 'Internet of Things' and smart technology documentary that will be filmed on the expo floor between November 3 to 5, 2015, in Santa Clara. NHK is the sole public TV network in Japan equivalent to the BBC in the UK and the largest in Asia with many award-winning science and technology programs. Japanese TV is producing a documentary about IoT and Smart technology and will be covering @ThingsExpo Silicon Val...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
As pervasive as cloud technology is -- and as persuasive as the arguments are for using it -- the cloud has its limits. Some companies will always have security concerns about storing data in the cloud and certain high-transaction applications will always be better suited for on-premises storage. Those statements were among the bottom-line takeaways delivered at Cloud Expo this week, a three day, bi-annual event focused on cloud technologies, adoption and associated challenges.
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
SYS-CON Events announced today that Hitachi Data Systems, a wholly owned subsidiary of Hitachi LTD., will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City. Hitachi Data Systems (HDS) will be featuring the Hitachi Content Platform (HCP) portfolio. This is the industry’s only offering that allows organizations to bring together object storage, file sync and share, cloud storage gateways, and sophisticated search an...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.